Hematopoietic Stem-Cell Transplantation in the Developing World: Experience from a Center in Western India

Table 1

Baseline patient characteristics and transplant data of our autologous and allogeneic patients.

Characteristics	Autologous	Allogeneic
(1) Total numbers ()	= 35	= 15
(2) Age (median)	50 years	21 years
(3) Gender (M : F)	28 : 7	13 : 2
(4) Indications	Multiple myeloma: 20; Non-Hodgkin lymphoma: 7; Hodgkin lymphoma: 5; Acute myeloid leukemia: 3	Chronic myeloid leukemia: 3; Aplastic anemia: 3; Thalassemia major: 3; Acute lymphoblastic leukemia: 2; Acute myeloid leukemia: 2; Myelodysplastic syndrome: 1; Non-Hodgkin lymphoma: 1
(5) Stem-cell source	All patients from peripheral blood	Peripheral blood: 11; Bone marrow: 4
(6) Stem-cell dose (median cell dose)	2.56^∧10^6 cells	5.15^∧10^6 cells
(7) Donor type	Not applicable	All siblings
(8) HLA matching	Not applicable	6/6 matched: = 14; 4/6 matched: = 1